Key result
Cryopreserved pulmonary allograft AVR yields ~87% event-free survival at three years without thromboembolism or endocarditis.
Why the study?
Does aortic valve replacement with cryopreserved pulmonary allograft provide safe and effective outcomes in patients requiring aortic valve replacement?
Population
89 patients requiring aortic valve replacement, including 16 with native or prosthetic valve endocarditis…
Design
Cohort
Follow-up
3 years
Authors
Loading...
May support cryopreserved pulmonary allografts in aortic valve replacement; leaves open need for randomized trials on durability and alternatives.
Cohort (n=89)
Does aortic valve replacement with cryopreserved pulmonary allograft provide safe and effective outcomes in patients requiring aortic valve replacement?
Cryopreserved pulmonary allografts for aortic valve replacement show favorable early to mid-term outcomes with 87% event-free survival at 3 years and no new endocarditis.
Konertz et al. (1994) conducted a cohort in Aortic valve disease requiring replacement (n=89). Cryopreserved pulmonary allografts was evaluated on Event-free survival at 3 years. Aortic valve replacement using cryopreserved pulmonary allografts demonstrated an 87% event-free survival at 3 years, with no thromboembolic events or new endocarditis observed.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: